Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Cardiothorac Vasc Anesth ; 20(3): 353-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16750735

ABSTRACT

OBJECTIVES: The purpose of this study was to compare the hemodynamic profiles and the postoperative insulin requirements in 2 groups of type 2 diabetic patients with depressed myocardial function who underwent elective surgery for coronary artery disease and who received levosimendan or milrinone for postcardiopulmonary bypass low-output syndrome. DESIGN: Randomized controlled trial. SETTING: The Chest Diseases Hospital, Safat, Kuwait. PARTICIPANTS: Type 2 diabetic patients undergoing elective surgery for coronary artery disease. INTERVENTIONS: Fourteen patients and 16 patients received levosimendan and milrinone infusions, respectively, for treatment of the low-output syndrome. MEASUREMENTS AND MAIN RESULTS: The hemodynamic, mixed venous oxygen saturation, oxygen extraction ratios, arterial lactate concentrations, and postoperative insulin infusion rates were serially documented for the first 48 hours after the diagnosis. The cardiac index and mixed venous oxygen saturation were significantly higher in the levosimendan group. The pulmonary capillary wedge pressure, systemic vascular resistance, and oxygen extraction ratios were significantly higher in the milrinone treatment group. The insulin requirements were similar for both of the treatment groups. CONCLUSIONS: Levosimendan was more efficient than milrinone for treating the hemodynamic manifestations of the postcardiopulmonary bypass low-output syndrome. However, all the values in the milrinone treatment group were normalized. In this small population, both treatment groups had similar postoperative insulin requirements.


Subject(s)
Cardiac Output, Low/drug therapy , Coronary Artery Bypass , Diabetes Mellitus, Type 2/physiopathology , Hydrazones/therapeutic use , Milrinone/therapeutic use , Phosphodiesterase Inhibitors/therapeutic use , Pyridazines/therapeutic use , Adult , Aged , Blood Pressure/drug effects , Cardiopulmonary Bypass/adverse effects , Elective Surgical Procedures , Female , Humans , Male , Middle Aged , Simendan , Stroke Volume/drug effects , Vascular Resistance/drug effects
3.
Cardiovasc Surg ; 11(3): 201-5, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12704329

ABSTRACT

Avoiding allogeneic blood transfusion during cardiac surgery and during the post-operative period is of great importance. Acute normovolemic hemodilution (ANH) is one of the options for blood salvage. We have prospectively analyzed 310 consecutive patients (pts) after different open heart procedures, operated on during April-May, 2000. ANH was possible in 226 pts (73%) with hemoglobin level over 125 g/l and hematocrit over 36%. Of those, one unit of blood was withdrawn in 128 pts (70%), while two to five units of blood were taken in 68 pts (30%). Total number of autologous blood units taken was 296, for the average of 1.31 units/pt. Predictors of increased intra- and post-operative blood loss were hematocrit (Hct) <39% (76% vs. 24%, p<0.001), age over 65 (p=0.028), female sex (p=0.006), CPB duration over 90 min (63% vs. 37%; p<0.001) and preoperative left ventricular ejection fraction (LVEF) <35% (63% vs. 37%; p<0.001). All pts with the above-mentioned characteristics were in need for allogeneic blood transfusion. During their hospital stay, 142 pts did not get allogeneic blood (142/310, 46%), and all were in the ANH group (142/226, 62%).


Subject(s)
Blood Transfusion , Heart Diseases/surgery , Hemodilution , Blood Volume , Female , Hematocrit , Hemoglobins/analysis , Hemostasis, Surgical , Humans , Intraoperative Period , Male , Middle Aged , Prospective Studies , Transplantation, Autologous
SELECTION OF CITATIONS
SEARCH DETAIL
...